Investors in Abzu

Abzu investors empower innovation.

The support of our investors has helped us to become the best in class in silico disease understanding and drug design company.

Abzu investors: The foundation of our future.

Driving breakthroughs in AI and pharma R&D.

The trust and resources invested in Abzu by our VC partners and the European Innovation Council have been pivotal in scaling our operations and research capabilities.

These investments in Abzu laid the foundation for us to unlock the future with explainable AI.

Abzu breakthroughs in discovery and AI

Abzu is an EIC Accelerator Grant recipient.

Achieving the pinnacle of EU funding.

In a remarkable endorsement of our ethical technology, European values, and our innovations in pharma R&D, Abzu has been honored with an EIC Accelerator Grant at its maximum funding capacity of €2.5 million.

Pre-seed and seed funding: The power of partnership.

Abzu has raised a total of € 10.2 million in VC funding.

Investment in Abzu is more than financial backing; it’s a belief in our potential to revolutionize disease understanding and drug design with our AI-driven approach.

Thanks to our investors:

One of the most experienced Nordic venture funds, Inventure specializes in helping with talent and expansion.

Vækstfonden supports successful businesses that grow the Danish economy and green the globe.

One of the best-performing funds in Europe, Seed Capital backs Danish founders all the way to exit.

One of Denmark’s most notable early-stage investors, PSV has a knack for identifying success early.

Interested in investing in Abzu?

Then we’re interested in getting to know you.

We are discerning in our selection of investment partners. If you share our vision for unlocking the future of drug development with explainable AI, then please complete the form below to start the conversation.

Entering your information above does not subscribe you to marketing emails from Abzu. It just makes it easier for us to get in touch with you. If you want to subscribe for information from Abzu, you can subscribe here.

Abzu is making headlines.

Abzu's innovative work in AI and pharma R&D makes waves in the scientific community and beyond.

February 7, 2024


Don’t settle for black box: Why only explainable AI is built for pharma.

June 12, 2023


AI in Pharma: Balancing Reality with Possibility.

May 5, 2023


20 Nordic startups to watch, according to investors.

May 9, 2022


Could Artificial Intelligence Provide the Key to Life Saving Medicines?

Subscribe for
notifications from Abzu.

You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.